微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.67% | -3.67% | -50.87% | 16/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 7.47% | 24.29% | -7.66% | 25/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 8.09% | 14.59% | 45.5% | 20/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 5.56% | 6.51% | 45.93% | 21/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 3.81% | 7.32% | -36.61% | 16/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 6.01% | 102.36% | -14.87% | 40/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 7.06% | 95.03% | 35.25% | 36/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 5.22% | 66.77% | 47.04% | 28/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 3.55% | 47.3% | 19.53% | 26/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 2.97% | -39.63% | -17.96% | 50/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 3.62% | -29.43% | 15.65% | 44/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 3.13% | 0.64% | 29.88% | 42/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.41% | 4.78% | -51.02% | 32/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 4.92% | 117.7% | -4.09% | 47/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 5.13% | 56.88% | 64.95% | 47/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 3.11% | 79.77% | 35.22% | 49/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.3% | 55.41% | 1.77% | 37/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 2.26% | 665% | -30.89% | 54/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 3.27% | -57.86% | 89.02% | 52/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 1.73% | -66.54% | 16.89% | 50/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 1.48% | -42.19% | 470% | 43/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | -0.4% | -104.51% | -105.15% | 57/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 7.76% | 4.72% | 50.1% | 31/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 5.17% | 9.3% | 101.95% | 30/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 2.56% | 20.75% | -71.11% | 36/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 8.86% | 25.32% | 19.57% | 38/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 7.41% | 34.48% | 56.66% | 33/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 4.73% | 20.97% | 123.11% | 33/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 2.12% | 37.66% | -70.01% | 40/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 7.07% | 490.61% | 28.31% | 46/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 5.51% | 114.4% | 40.92% | 46/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 3.91% | 162.42% | 153.9% | 44/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 1.54% | -40.08% | 185.08% | 43/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | -1.81% | -117.24% | -170.43% | 63/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 2.57% | -76.87% | 72.48% | 50/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 1.49% | -77.49% | -42.02% | 54/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 2.57% | -30.73% | -75.52% | 31/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 10.5% | 13.51% | -5.49% | 36/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 11.11% | 37.84% | 67.82% | 20/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 6.62% | 24.67% | 78.44% | 27/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 3.71% | 36.4% | -59.89% | 19/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |